Thank you for your interest
We have a lot of exciting things going on and would be honored if you joined us.
Heugenis will be launching a REG A IPO in the first quarter of 2019. Contact us if you'd like to learn more about investment opportunities, or if you would like to learn how you can get on an advance list to receive our groundbreaking technology.
Please contact me by email for personalized information.
Heugenis™ Inc is focused on bringing hope to millions suffering from Alzheimer’s disease through an easy to use, low cost, non-invasive and non-drug approach.
Building on decades of clinical and university studies, Heugenis Inc is committed to developing a new generation of affordable non-drug related medical solutions, offered direct to consumers on an expedited timeline through the rapid-adoption of pioneering research.
Our company is built on the past success of our Founders, who have a demonstrated track record for bringing innovative ideas to the global marketplace.
Our first priority at Heugenis Inc will always be to serve the urgent need of Alzheimer’s sufferers and their caregivers with empathy, respect, and integrity, with the goal of delivering hope to millions living with this debilitating disease.